Nifty

:

10710.80

Sensex

:

36093.47

-129.85 (-1.20%)
-470.41 (-1.29%)

Login

Nifty
Sensex

:
:

10710.80
36093.47

-129.85 (-1.20%)
-470.41 (-1.29%)

Wintac Ltd.

Pharmaceuticals & Drugs

Rating :

62/99

BSE: 524758 | NSE: Not Listed

Watchlist

NSE BSE

170.10

18-Sep-2019

Open
High
Low
Previous Close

172.10
174.95
160.10
179.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

24
0.56
239.30
141.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

170.51
34.71
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

236.90
N/A
-36.23

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.21
19.53
29.91

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
25.84
-4.60

PAT CAGR (%)

10 Years
5 Years
3 Years

-20.85
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

16.27
23.42
32.24

EV:EBITDA (Average)

8 Years
5 Years
3 Years

31.92
42.75
67.51

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 17.82 13.11 35.93% 25.27 10.67 136.83% 19.38 10.41 86.17% 14.17 12.02 17.89%
Expenses 17.00 17.09 -0.53% 20.00 14.46 38.31% 15.74 11.68 34.76% 18.16 11.92 52.35%
EBITDA 0.83 -3.98 - 5.27 -3.80 - 3.63 -1.27 - -3.99 0.10 -
EBIDTM 4.65% -30.42% 20.86% -35.59% 18.75% -12.18% -28.15% 0.87%
Other Income 0.16 0.04 300.00% 0.78 0.61 27.87% 3.10 0.45 588.89% 0.48 0.03 1,500.00%
Interest 0.10 0.20 -50.00% 0.10 0.30 -66.67% 0.05 0.19 -73.68% 0.58 0.22 163.64%
Depreciation 1.35 0.93 45.16% 1.15 0.94 22.34% 1.06 0.89 19.10% 1.04 0.86 20.93%
PBT -0.47 -5.08 - 4.80 -4.42 - 5.62 -1.95 - -5.13 -0.94 -
Tax -0.14 0.05 - 0.40 0.77 -48.05% -0.27 -1.36 - -0.08 0.68 -
PAT -0.33 -5.13 - 4.40 -5.19 - 5.88 -0.59 - -5.05 -1.62 -
PATM -1.82% -39.13% 17.42% -48.63% 30.36% -5.68% -35.63% -13.49%
EPS -0.32 -5.12 - 4.39 -5.17 - 5.87 -0.59 - -5.04 -1.62 -

Description Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 76.64 71.92 44.35 32.80 18.10 29.47 30.48 20.88 24.27 26.67 20.79 Net Sales Growth 65.85% 62.16% 35.21% 81.22% -38.58% -3.31% 45.98% -13.97% -9.00% 28.28% Cost Of Goods Sold 28.80 8.09 8.54 8.78 5.29 6.73 7.33 4.11 6.45 5.36 3.46 Gross Profit 47.84 63.82 35.82 24.02 12.80 22.74 23.14 16.77 17.82 21.31 17.33 GP Margin 62.42% 88.74% 80.77% 73.23% 70.72% 77.16% 75.92% 80.32% 73.42% 79.90% 83.36% Total Expenditure 70.90 77.98 50.32 40.47 31.43 31.39 31.91 23.93 24.62 21.80 17.06 Power & Fuel Cost - 5.70 4.39 4.08 3.19 3.38 3.51 2.97 2.87 2.44 2.24 % Of Sales - 7.93% 9.90% 12.44% 17.62% 11.47% 11.52% 14.22% 11.83% 9.15% 10.77% Employee Cost - 23.25 17.99 15.03 12.88 11.26 9.59 7.94 7.49 6.46 5.13 % Of Sales - 32.33% 40.56% 45.82% 71.16% 38.21% 31.46% 38.03% 30.86% 24.22% 24.68% Manufacturing Exp. - 21.99 12.98 8.07 6.59 6.13 7.21 4.97 5.60 4.41 3.75 % Of Sales - 30.58% 29.27% 24.60% 36.41% 20.80% 23.65% 23.80% 23.07% 16.54% 18.04% General & Admin Exp. - 2.78 4.73 3.39 2.16 2.83 3.18 2.44 1.40 1.24 1.35 % Of Sales - 3.87% 10.67% 10.34% 11.93% 9.60% 10.43% 11.69% 5.77% 4.65% 6.49% Selling & Distn. Exp. - 0.12 0.08 0.06 0.12 0.10 0.19 0.35 0.27 0.36 0.75 % Of Sales - 0.17% 0.18% 0.18% 0.66% 0.34% 0.62% 1.68% 1.11% 1.35% 3.61% Miscellaneous Exp. - 16.04 1.62 1.06 1.19 0.96 0.89 1.16 0.53 1.53 0.75 % Of Sales - 22.30% 3.65% 3.23% 6.57% 3.26% 2.92% 5.56% 2.18% 5.74% 1.83% EBITDA 5.74 -6.06 -5.97 -7.67 -13.33 -1.92 -1.43 -3.05 -0.35 4.87 3.73 EBITDA Margin 7.49% -8.43% -13.46% -23.38% -73.65% -6.52% -4.69% -14.61% -1.44% 18.26% 17.94% Other Income 4.52 11.38 0.72 1.44 0.18 0.14 0.63 0.35 0.25 0.10 0.61 Interest 0.83 0.93 0.90 1.00 0.94 0.15 0.29 2.82 3.00 2.50 1.75 Depreciation 4.60 4.18 3.55 3.63 3.87 3.64 1.88 1.94 1.96 1.71 1.46 PBT 4.82 0.21 -9.70 -10.86 -17.95 -5.56 -2.98 -7.46 -5.07 0.76 1.14 Tax -0.09 0.10 0.09 -1.21 -1.21 -1.51 0.52 -0.58 0.31 -0.02 0.00 Tax Rate -1.87% 47.62% -0.93% 12.51% 7.41% 19.71% -8.04% 3.26% -6.10% -2.63% 0.00% PAT 4.90 0.11 -9.79 -8.46 -15.13 -6.15 -6.99 -17.20 -5.38 0.78 1.14 PAT before Minority Interest 4.90 0.11 -9.79 -8.46 -15.13 -6.15 -6.99 -17.20 -5.38 0.78 1.14 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.39% 0.15% -22.07% -25.79% -83.59% -20.87% -22.93% -82.38% -22.17% 2.92% 5.48% PAT Growth 139.11% - - - - - - - - -31.58% Unadjusted EPS 4.90 0.11 -9.77 -8.44 -15.10 -6.14 -6.98 -25.79 -10.26 0.57 1.35

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds -4.38 -4.22 5.67 14.12 29.25 35.40 44.40 21.60 23.08 19.47 Share Capital 10.02 10.02 10.02 10.03 10.03 10.03 12.03 8.03 7.54 7.54 Total Reserves -14.41 -14.25 -4.35 4.09 19.22 25.37 32.37 13.57 15.54 11.93 Non-Current Liabilities 8.60 -0.88 -0.05 3.07 -4.08 -2.18 -2.10 5.47 4.42 14.23 Secured Loans 0.00 5.44 6.41 8.29 0.00 0.00 0.00 5.73 5.50 6.67 Unsecured Loans 13.78 0.00 0.00 0.00 0.00 0.39 0.97 2.22 1.71 7.56 Long Term Provisions 1.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 125.46 71.37 45.96 30.59 20.25 15.91 15.31 23.15 25.06 7.76 Trade Payables 12.65 4.75 6.25 5.83 5.20 7.91 6.51 5.95 6.33 2.64 Other Current Liabilities 61.49 64.69 38.18 23.70 14.34 7.62 7.36 8.68 8.25 5.12 Short Term Borrowings 50.17 0.00 0.25 0.25 0.00 0.00 1.25 7.98 10.01 0.00 Short Term Provisions 1.16 1.94 1.28 0.81 0.71 0.38 0.19 0.54 0.48 0.00 Total Liabilities 129.68 66.27 51.58 47.78 45.42 49.13 57.61 50.22 52.56 41.46 Net Block 51.61 31.66 31.67 31.51 31.69 29.89 22.44 24.81 23.99 20.77 Gross Block 62.84 38.83 35.29 56.18 52.49 47.42 38.00 41.09 38.31 33.41 Accumulated Depreciation 11.23 7.17 3.62 24.67 20.80 17.52 15.57 16.28 14.32 12.64 Non Current Assets 97.72 48.75 34.02 36.67 36.12 34.05 27.79 38.74 36.63 21.75 Capital Work in Progress 39.31 6.13 0.05 2.45 0.01 0.00 2.10 1.50 0.73 0.08 Non Current Investment 0.43 0.00 0.00 0.00 0.00 0.00 0.00 0.90 0.90 0.90 Long Term Loans & Adv. 5.41 10.96 2.30 0.68 1.98 1.88 1.85 10.27 10.29 0.00 Other Non Current Assets 0.96 0.00 0.00 2.03 2.44 2.28 1.40 1.25 0.72 0.00 Current Assets 31.96 17.52 17.57 11.10 9.30 15.08 29.82 11.49 15.94 19.72 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 19.45 9.04 7.86 6.52 4.85 6.25 4.64 4.90 5.58 2.70 Sundry Debtors 1.92 0.80 3.63 2.92 2.48 5.75 3.68 4.28 7.66 5.75 Cash & Bank 0.06 0.54 0.01 0.30 0.42 0.61 17.84 1.32 1.41 0.75 Other Current Assets 10.54 0.97 5.69 0.69 1.54 2.48 3.66 0.99 1.28 10.52 Short Term Loans & Adv. 7.13 6.18 0.38 0.67 0.64 1.69 0.65 0.51 0.03 10.52 Net Current Assets -93.50 -53.85 -28.40 -19.49 -10.95 -0.83 14.51 -11.67 -9.12 11.95 Total Assets 129.68 66.27 51.59 47.77 45.42 49.13 57.61 50.23 52.57 41.47

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity -4.08 18.20 4.25 -3.90 6.03 -6.50 -3.01 3.85 3.46 2.30 PBT 0.21 -9.70 -9.67 -16.34 -7.67 -6.47 -17.78 -5.08 0.81 1.14 Adjustment 4.92 4.16 4.55 5.07 5.59 1.45 14.64 4.85 4.12 3.22 Changes in Working Capital -9.18 23.74 9.37 7.37 8.10 -1.48 0.13 4.08 -1.47 -2.05 Cash after chg. in Working capital -4.05 18.20 4.25 -3.90 6.03 -6.50 -3.01 3.85 3.46 2.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -55.54 -15.54 -1.72 -4.82 -5.53 -7.05 -0.49 -3.58 -6.43 -2.34 Net Fixed Assets -57.19 -9.62 23.29 -6.13 -5.08 -7.32 2.49 -3.55 -5.55 -1.30 Net Investments -0.43 0.00 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 Others 2.08 -5.92 -25.01 1.31 -0.45 0.27 -3.88 -0.03 -0.88 -1.04 Cash from Financing Activity 59.15 -2.13 -2.81 8.63 -0.70 -3.68 20.01 -0.36 3.64 0.14 Net Cash Inflow / Outflow -0.47 0.53 -0.29 -0.08 -0.20 -17.23 16.51 -0.09 0.66 0.10 Opening Cash & Equivalents 0.54 0.01 0.30 0.38 0.58 17.81 1.32 1.41 0.75 0.64 Closing Cash & Equivalent 0.06 0.54 0.01 0.30 0.38 0.58 17.84 1.32 1.41 0.75

Financial Ratios

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) -4.37 -4.21 5.66 14.08 29.17 35.31 42.29 32.52 42.01 34.42 ROA 0.11% -16.62% -17.03% -32.48% -13.02% -13.11% -31.90% -10.47% 1.66% 2.80% ROE 0.00% -1348.67% -85.52% -69.81% -19.04% -17.98% -55.50% -27.14% 4.28% 7.16% ROCE 3.54% -109.91% -46.39% -57.64% -22.79% -14.61% -33.55% -4.93% 8.45% 8.89% Fixed Asset Turnover 1.42 1.21 0.76 0.37 0.61 0.77 0.57 0.65 0.77 0.68 Receivable days 6.89 18.02 34.22 49.03 49.13 52.66 64.07 84.03 88.10 85.47 Inventory Days 72.29 68.87 75.25 103.23 66.22 60.77 76.76 73.78 54.42 46.66 Payable days 48.98 41.79 55.22 63.09 80.53 84.89 101.42 89.53 79.79 55.71 Cash Conversion Cycle 30.19 45.10 54.25 89.17 34.82 28.53 39.42 68.28 62.73 76.42 Total Debt/Equity -15.17 -1.59 1.39 0.69 0.01 0.03 0.09 0.90 0.88 0.73 Interest Cover 1.22 -9.79 -8.70 -16.40 -49.97 -21.13 -5.30 -0.69 1.30 1.65

Top Investors:

bangalore pharmaceutical and research lab pvt ltd

s.t.raghavendra mady

s.jayaprakash mady

Annual Reports:

News Update:

Wintac - Quarterly Results
12th Aug 2019, 15:07 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback